Sara A. Hurvitz, MD | Authors

Sara Hurvitz, MD, Speaks to Improvements in Treatment for HER2+ Breast Cancer

May 29, 2022

Sara Hurvitz, MD, spoke to the difficulty of treating HER2-positive and advanced HER2-positive breast cancer and how the efficacy of novel agents such as fam-trastuzumab deruxtecan-nxki could make a difference in treating the disease.